ERAS
Price
$1.45
Change
+$0.03 (+2.11%)
Updated
Jun 3 closing price
Capitalization
409.35M
64 days until earnings call
LRMR
Price
$2.40
Change
-$0.01 (-0.41%)
Updated
Jun 4, 10:30 AM (EDT)
Capitalization
141.18M
64 days until earnings call
Interact to see
Advertisement

ERAS vs LRMR

Header iconERAS vs LRMR Comparison
Open Charts ERAS vs LRMRBanner chart's image
Erasca
Price$1.45
Change+$0.03 (+2.11%)
Volume$2.04M
Capitalization409.35M
Larimar Therapeutics
Price$2.40
Change-$0.01 (-0.41%)
Volume$4.82K
Capitalization141.18M
ERAS vs LRMR Comparison Chart
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. LRMR commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a Buy and LRMR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ERAS: $1.45 vs. LRMR: $2.41)
Brand notoriety: ERAS and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 123% vs. LRMR: 91%
Market capitalization -- ERAS: $409.35M vs. LRMR: $141.18M
ERAS [@Biotechnology] is valued at $409.35M. LRMR’s [@Biotechnology] market capitalization is $141.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, ERAS is a better buy in the long-term than LRMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 6 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • ERAS’s TA Score: 6 bullish, 4 bearish.
  • LRMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than LRMR.

Price Growth

ERAS (@Biotechnology) experienced а +33.80% price change this week, while LRMR (@Biotechnology) price change was +31.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ERAS is expected to report earnings on Aug 07, 2025.

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERAS($409M) has a higher market cap than LRMR($141M). LRMR YTD gains are higher at: -37.726 vs. ERAS (-42.430). LRMR has higher annual earnings (EBITDA): -105.02M vs. ERAS (-151.33M). ERAS has more cash in the bank: 319M vs. LRMR (158M). LRMR has less debt than ERAS: LRMR (4.87M) vs ERAS (52.9M). ERAS (0) and LRMR (0) have equivalent revenues.
ERASLRMRERAS / LRMR
Capitalization409M141M290%
EBITDA-151.33M-105.02M144%
Gain YTD-42.430-37.726112%
P/E RatioN/AN/A-
Revenue00-
Total Cash319M158M202%
Total Debt52.9M4.87M1,087%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASLRMR
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGINX72.170.46
+0.64%
Janus Henderson Growth And Income I
SAOPX14.52N/A
N/A
Barrett Opportunity Retail
ARYCX25.40N/A
N/A
American Century Real Estate C
TDFAX8.16N/A
N/A
Transamerica Sustainable Equity Inc A
JSGCX24.47N/A
N/A
JHancock U.S. Growth C

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with RVMD. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
+1.40%
RVMD - ERAS
57%
Loosely correlated
-0.17%
LRMR - ERAS
56%
Loosely correlated
+9.30%
XNCR - ERAS
54%
Loosely correlated
+6.53%
ATXS - ERAS
53%
Loosely correlated
+3.77%
APGE - ERAS
53%
Loosely correlated
+2.06%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+9.30%
ERAS - LRMR
53%
Loosely correlated
+1.40%
IMNM - LRMR
50%
Loosely correlated
+2.21%
ACLX - LRMR
49%
Loosely correlated
+5.18%
ATXS - LRMR
49%
Loosely correlated
+3.77%
COGT - LRMR
48%
Loosely correlated
+3.21%
More